Duality Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,131
Closed -$6.82M 277
2024
Q1
$6.82M Buy
43,131
+20,615
+92% +$3.28M 0.67% 7
2023
Q4
$3.53M Buy
+22,516
New +$3.45M 0.37% 69
2023
Q2
Sell
-34,246
Closed -$5.31M 627
2023
Q1
$5.31M Buy
34,246
+9,667
+39% +$1.56M 0.6% 8
2022
Q4
$4.34M Buy
+24,579
New +$4.24M 0.49% 33
2022
Q3
Sell
-2,699
Closed -$479K 641
2022
Q2
$479K Buy
+2,699
New +$481K 0.05% 472
2022
Q1
Sell
-37,991
Closed -$6.5M 730
2021
Q4
$6.5M Buy
+37,991
New +$6.22M 0.7% 19
2021
Q3
Sell
-9,753
Closed -$1.61M 626
2021
Q2
$1.61M Buy
+9,753
New +$1.61M 0.14% 246
2020
Q4
Sell
-15,070
Closed -$2.24M 642
2020
Q3
$2.24M Sell
15,070
-24,987
-62% -$3.7M 0.14% 202
2020
Q2
$5.63M Buy
+40,057
New +$5.84M 0.51% 44
2019
Q2
Sell
-123,880
Closed -$17.3M 260
2019
Q1
$17.3M Buy
+123,880
New +$16.6M 1.02% 13

Other funds holding JNJ

Duality Advisers's JNJ Position: Q2 2024 in Review

Duality Advisers sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 43,131 shares — an estimated $6.82M sold.

Duality Advisers first reported a position in JNJ in Q1 2019 and held it in 10 quarters. The position peaked at $17.3M in Q1 2019. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Duality Advisers reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 43,131 Johnson & Johnson shares in Q2 2024, an estimated $6.82M.
  • Duality Advisers first reported a position in Johnson & Johnson in Q1 2019 and held it in 10 quarters.
  • Duality Advisers's Johnson & Johnson position peaked at $17.3M in Q1 2019.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.